Peters, Jay ISchool of Medicine |
|
| 4/2009 - Present | Chief, Division of Pulmonary and Critical Care Medicine | University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 1/2009 - Present | Adjunct Professor Pharmaceutics | University of Texas at Austin, Pharmacology, Austin, TX |
| 9/1996 - Present | ACLS Instructor | South Texas Veterans Healthcare System, San Antonio, TX |
| 9/1996 - Present | Chair, Cold Blue Committee | South Texas Veterans Health Care System, Medicine, San Antonio, TX |
| 9/1996 - Present | Professor | The University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 9/1996 - Present | Chair, Critical Care Committee | South Texas Veterans Health Care System, Medicine, San Antonio, TX |
| 9/1994 - Present | Medical Director | University of Texas Health Science Center at San Antonio, Department of Respiratory Therapy, San Antonio, TX |
| 8/1994 - Present | Medical Director | School of Allied Health, San Antonio, TX |
| 6/1984 - Present | Staff Physician and Staff Physician | The South Texas Veterans Healthcare System, Audie L Murphy Division, Pulmonary Diseases and Critical Care, San Antonio, TX |
| 6/1984 - Present | Assistant Foundation Scientist | Southwest Foundation for Biomedical Research, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 1983 | Postdoctoral Fellowship | Pulmonary/Critical Care/Infectious Disease (Pulmonary/Critical Care/Infectious Disease Fellowship) | Baylor College of Medicine Houston , TX |
| 1980 | Postdoctoral Fellowship | Internship and Residency (Infectious Diseases) | Baylor College of Medicine Houston , TX |
| 1980 | Residency | Chief Medical Resident (Chief Medical Resident, 7/80 - 12/80) | Baylor College of Medicine Houston , TX |
| 1976 | MD | Medicine (Alpha Omega Alpha) | Baylor College of Medicine Houston , TX |
| 1973 | BA | (Magna Cum Laude) | University of Texas at Austin Austin , TX |
| 1970 | BA | (Honors & Scholars Program) | Tulane University New Orleans , LA |
| Date | Description | Institution | # Students |
| 11/2013 - Present | Grand Rounds - Asthma 2013:Pathogenesis, Therapies and Controversies | North Shore LIJ | 100 students |
| 1/2012 - Present | Pre-Doctoral Student Supervision | University of Texas at Austin | |
| 1/2012 - Present | Pre-Doctoral Student Supervision | University of Texas at Austin | |
| 9/2008 - Present | Dilemma`s in the ICU | University of Texas Health Science Center at San Antonio | 50 students |
| Medical School Ethics Presentation | |||
| 7/2006 - Present | On Becoming a Doctor ? Foundations | The University of Texas Health Science Center | |
| 7/2006 - Present | Adv Clin Eval Skills | The University of Texas Health Science Center | |
| 6/2006 - Present | Internal Medicine Morning Report | University of Texas Health Science Center at San Antonio | 50 students |
| Faculty discussion for daily intern and resident morning conference. | |||
| 1/2006 - Present | Pre-Doctoral Student Supervision | University of Texas at Austin College of Pharmacy/UTHSCSA | |
| 7/2000 - Present | Intro to Clin Medicine | The University of Texas Health Science Center | |
| Annual Pulmonary ACES Course: Pre-clinical teaching using patients with a variety of pulmonary diseases (i.e., very severe chronic obstructive pulmonary disease, pulmonary fibrosis, and/or post-lung transplant) to emphasize physical exam techniques that emphasize the identification and diagnosis of pulmonary problems. | |||
| 9/1996 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1994 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1993 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1992 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1988 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1988 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1985 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1984 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 7/1984 - Present | Post-Doctoral Student Supervision | The University of Texas Health Science Center at San Antonio and South TX Veterans Healthcare System | |
| 7/1984 - Present | Off Campus | The University of Texas Health Science Center | 10 students |
| Medicine Thoracic Clinic Attending, University Hospital-Downtown: 1/2 day clinic per week, 6-8 weeks, 5-6 contact hours/week. | |||
| 7/1984 - Present | Clinical Medicine II | The University of Texas Health Science Center | 10 students |
| South Texas Veterans Healthcare System, Pulmonary Clinic Attending: 1/2 day clinic per week for 16 weeks, 5-6 contact hours per week. | |||
| 7/1984 - Present | Clinical Medicine | The University of Texas Health Science Center | 20 students |
Abstract |
| Peters JI, Maselli DJ. Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation o fexacerbations, emergency department visits, lung function, and oral corticosteroid use; 2018 Oct. (Ther Clin Risk Manag). |
| Restrepo MI. Intratracheal Administration of Mesenchymal Stem Cells Improves survival in a mouse model of severe pneumococcal pneumonia; 2017 May. (American Thoracic Society International Conference). |
| Estrada RA, Maselli DJ, Peters JI. Severe Dyspnea: A bone of Contention. American Thoracic Society Annual Meeting Washington, DC: American Thoracic Society; 2017 May. (ATS Annual Meeting). |
| Peters JI. Callithrix jacchus: a non-human primate model of mycobacterium avium complex pulmonary infection?; 2017 May. |
| Peters JI. Pleuran Fluid pH: Comparing analytical methods and the Impact on clinical decision making; 2017 May. |
| N.A. Hanania, S. S Braman, J. Ohar, Adams SG, A. Ari, S. Sanjar, J. Brooks, Peters JI, D.A. Mahler, Adewuya. Exploring Health Care Providers` Practice Gaps in Prescribing Inhalation Delivery Devices for the Management of COPD. Resultos from the Delivery Makes a Difference (DMaD) Survey: SUNOVION; 2017 Jan. (CHEST). |
| Amalakuhan Bravein, King Phoebe C, Peters JI, Malave AJ. "Itching from the Skin to the Lungs: case of Varicella pneumonia ?; 2015 Oct. (Chest). |
| Sha Liu, Allan B. Watts, Ju Du, Amanda Bui, Soraya Hengsawas, Peters JI, Robert O. Williams III. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery; 2015 Jul. (Eur J Pharm Biopharm). |
| Mangat M, Amalakuhan B, Habib S, Reyes L, Anzueto AR, Levine SM, Peters JI, Restrepo MI. High Endocan Levels Predict the Need for Ventilatory Support Among Patients With Severe Sepsis; 2015 Jan. |
| Peters JI. Improved Inhaled Combination therapies through particle engineerin; 2015 Jan. |
| Peters JI. Activation of the Inflammasome is not associated iwth multiorgan failure in bacteremic Patients with severe sepsis; 2015 Jan. (CHEST). |
| Peters JI. Not your straighforward septic patient; 2015 Jan. (Am j Respir Crit Care Med). |
| Peters JI. ElevatedVascular Endothelial Injury markers are associated with the development of multiorgan failure and mortality in patients with severe sepsis and septic shock; 2015 Jan. (CHEST). |
| Yi-Bo Wang, Alan B. Watts, Peters JI, Robert O. Williams III. The Impact of Pulmonary Diseases on the Fate of Inhaled Medicines; 2014 Jan. (International Journal of Pharmaceutics; vol. 461, no. 1-2). |
| Peters JI. Cardiac constriction in a young male; 2014 Jan. |
| Levine SM, Singh H, Williams R, O`Donnell K., Lang B, Wang Y, Anzueto AR, Talbert R., Peters JI. Safety and Tolerability of Single Dose Inhaled Dry Powder Tacrolimus in Healthy Subjects; 2013 Oct. (Chest Meeting Abstracts). |
| Peters JI. Identification of CARDS toxin in the bronchial epithelial lining fluid after mycoplasma pneumoniae(Mp) inoculation: A primate Model; 2013 Oct. |
| Bayer, J, Das NA, Baisden CE, Rani M, Schwacha MG, Sako EY, Williams, RO, Peters JI, Johnson SB. Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model Minneapolis, MN; 2013 May. (93rd Annual Meeting of The American Association for Thoracic Surgery; vol. 146, no. 5). |
| Watts, AB, Wang, Y, Carvalho, S, Peters JI, Williams, RO. A Comprehensive DPI Platform for Delivery of Small Molecules and Biologics; 2013 Jan. (American Thoracic International Conference Abstracts; vol. 276, no. A4114). |
| Susanto IS, Sako EY, Anzueto AR, Levine SM, Peters JI, Cronin T, Jenkinson SG, Bryan C. Outcome of single lung transplants from the same donor: "Pulmonary Twinning"; 1995 Oct. (Chest; vol. 108, no. 3). |
Book Chapter |
| Shelledy DC, Peters JI. Introduction to Patient Assessment (Chapter 1). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones And Bartlett; 2014. p. 1-22. |
| Arora Anisha, Diaz Karla, Peters JI, Malave AJ. Bronchoscopy and other Diagnostic Studies(Chapter 13). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones and Bartlett; 2014. p. 543-555. |
| Vasquez Laura P., Shelledy DC, Peters JI. Cardiopulmonary Imaging (Chapter 11). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones and Bartlett; 2014. p. 428-498. |
| Shelledy DC, Peters JI. Patient History (Chapter 4). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones and Bartlett; 2014. p. 87-136. |
| Shelledy DC, Peters JI. Development and Implementation of Respiratory Care Plans (Chapter 2). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones And Bartlett; 2014. p. 23-58. |
| Burguete SR, DeArmond DT, Peters JI. Pneumothorax (in press). In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM. Fishman's Pulmonary Diseases and Disorders, 5th edition (in press). NY: McGraw Hill; 2013. |
| Peters JI, Levine SM. Introduction to Pulmonary Function Testing, Chapter 32 (In press). In: Edited by J.T. DiPiro, R. L. Tabert, G.C Yee, G.R. Matzke, B.G Wells, L.M. Posey. Pharmacotherapy: A Pathophysiologic Approach. 2013. |
Book/Monograph |
| Peters JI, Shelledy, David, Editor and co- authored for four chapters. Textbook of Respiratory Care Burlington,Mass: Jones and Bartlet Learning; 2014. |
Editorial |
| Mangat M, Amalakuhan B, Habib, Sheila, Reyes, LF, Hinojosa CA, Rodriguez AH, Soni NJ, Anzueto AR, Levine SM, Peters JI, Aliberti S, Sibila O, Rello J, Witzenrath M, Waterer G, Martin Loceches, Blanquer J, Sanz F, Marcos PJ, Sole-Violan, Chalmers JD, Feldman C, Wunderink RG, Cruz CSD, Orijuela CJ, Restrepo MI. High Endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis Eur Respir J 2017 Jul;50(1):1-4. |
| Maselli DJ, Peters JI. Five days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation Ann Intern Med 2013 Sep;159(6):5-5. |
| Adams SG, Peters JI. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD Annals of Internal Medicine ACP Journal Club 2013 Mar;158(6):3-3. |
Electronic/Web Publication |
| Peters JI. Macrolides for Severe Asthma 2017 Jul. |
| Peters JI. E-cigarettes 2017 Jul. Available from: https://foundation.chestnet.org/e-cigarettes/ . |
| Peters JI. Smoking and Tobacco Use 2017 Jan. Available from: https://foundation.chestnet.org/patient-education-resources/smoking/ . |
| Peters JI. COPD: American Lung Association/American College of Chest Physicians 2016 Jun. |
| Peters JI. Pulmonary Arterial Hypertension: American Lung Association/American College of Chest Physicians 2016 Jun. |
| Peters JI. Asthma: American Lung Association/American College of Chest Physicians 2016 May. |
| Peters JI. Sarcoidosis: American Lung Association/American College of Chest Physicians 2016 May. |
| Peters JI. Case Studies in COPD: Therapy and Prevention of Exacerbations, Self Study Educational Module 2013 Sep. |
Journal Article |
| Peters JI. Pooled RCTs: Adding LABAs to ICS do not increase serious asthma events and reduce exacerbations ACP Journal Club 2018 Oct;. |
| Peters JI, Maselli DJ. Medication Regimens for Managing Acute Asthma Respir Care 2018 Jun;63(6):783-796. |
| Peters JI, Maselli DJ. Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbations N engl J Med 2018 Jan;378:902-910. |
| Nicola Hanania, Sidney Braman, Adams SG, Ruth Adewuya, Arzu Ari, JoAnn Brooks, Donald Mahler, Jill Ohar, Peters JI, Shanhin Sanjar. The Role of Inhalatin Delivery Devices in COPD: Perspectives of patients and health care providers Journal of the COPD foundation 2018 Jan;5(2). |
| Das NA, Peters JI, Jeremy D. Simmons, Yibo Wang, Kevin P. O`Donnell, DeArmond DT, Coalson JJ, Brooks EG, Johnson SB. The efficacy of inhaled nanoparticle tacrolimus in preventing rejection in an orthotopic rat lung transplant model The Journal of Thoracic and Cardiovascular Surgery 2017 Dec;154(6):2144-2151. |
| Fernandez-Restrepo L, Shaffer L, Amalakuhan B, Restrepo MI, Peters JI, Restrepo RD. Effects of intrapulmonary percussive ventilation on airway mucus clearance: a bench model World Journal of Critical Care Medicine 2017 Oct;. |
| Maselli DJ, Peters JI. In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months Annals of Internal Medicine 2017 Oct;. |
| Maselli DJ, Medina JL, Brooks EG, Coalson JJ, Kannan TR, Winter VT, Principe M, Cagle MP, Baseman JB, Dube PH, Peters JI. The immunopathologic effects of Mycoplasma pneumoniae and CARDS toxin: a primate model Am J Respir Cell Mol Bio 2017 Sep;. |
| Pamela Wood, MD; Jordan C Kampschmidt, BS; Peter H Dube, PhD; Marianna P Cagle, MA; Paola Chaparro, MS; Norma Ketchum; Thirumalai R Kannan, PhD; Harjinder Singh, MD; Jay I Peters, MD; Joel B Baseman, PhD; Edward G Brooks, MD. Mycoplasma pneumoniae and health outcomes in children with asthma Annals of Allergy, Asthma & Immunology 2017 Aug;. |
| Peters JI. Oral Glucocorticoid-sparing effect of benralizumab in severe asthma American College Physician Journal Club 2017 Jul;. |
| Nambiar AM, Anzueto AR, Peters JI. Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis PloS ONE 2017 Apr;12(4). |
| Peters JI. Attenuation of lung and tumor fibrosis by fibroblast-specific inhibition of TGFB1 signaling Journal of Clinical Investigation 2017 Jan;. |
| Jorge Villalpando, Peters JI, Adams SG. Inducible laryngeal obstruction/vocal cord dysfunction and the role it plays in refractory asthma Arch Asthma Allergy Immunol 2017 Jan;. |
| Julien Maincent, Laura K. Najvar, William R. Kirkpatrick, Siyuan Huang, Thomas F. Patterson, Nathan P. Wiederhold, Peters JI, Robert O. Williams III. Modified Release Itraconazole Amorphous Solid Dispersion to Treat Aspergillus fumigatus: Importance of the Animal Model Selection. (In Press) Drug Development and Industrial Pharmacy 2016 Sep;. |
| Soto-Gomez N, Peters JI, Nambiar AM. Diagnosis and Management of Sarcoidosis Am Fam Physician 2016 May;93(10):840-848. |
| Maselli DJ, Peters JI. ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide Annals of Internal Medicine 2016 Jan;164(2):6-6. |
| Maselli DJ, Peters JI. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthma Annals of Internal Medicine 2015 Jun;162(12):5-5. |
| Shivshankar P, Payan H, Calhoun C, Levine SM, William R, Jagirdar J, Peters JI, Le Saux CJ. Inhaled Tacrolimus Modulates Pulmonary Fibrosis without Promoting Inflammation in Bleomycin-Injured Mouse Lungs Journal of Drug Delivery Science and Technology 2014 Sep;24(5):469-477. |
| Wiener RS, Ouellette DR, Diamond E, Fan VS, Maurer JR, Mularski RA, Peters JI, Halpern SD. An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine Chest 2014 Jun;145(6):1383-1391. |
| Wang YB, Watts AB, Peters JI, Liu S, Batra A, Williams RO. In Vitro and In Vivo Performance of Dry Powder Inhalation Formulations: Comparison of Particles Prepared by thin Film Freezing and Micronization. Epub AAPS PharmSciTech 2014 May;. |
| Renda Soylemez Wiener, Ouellette DR, Edward Diamond, Vincent S. Fan, Janet R. Maurer, Richard A. Mularski, Peters JI, Scott D. Halpern. The Choosing Wisely Top Five List in Adult Pulmonary Medicine Chest 2014 Jan;. |
| Hung JY, Horn, Diane, Woodruff, Kathleen, Prihoda, Thomas, LeSaux, Claude, Peters JI, Tio FO, Werner SL. Colony Stimulating Factor 1 Potentiates Lung Cancer Bone Metastasis Laboratory Investigation 2014 Jan;94(4):371-381. |
| Maselli DJ, Peters JI. 5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation Annals Internal Medicine 2013 Sep;159(6):5-5. |
| Bayer J, Das NA, Basiden CE, Rani M, Schwacha MG, Sako EY, Williams RO, Peters JI, Johnson SB. Effect of inhaled tacrolimus on ischemia reperfusion injury in a rat lung transplant model The Journal of Thoracic and Cardiovascular Surgery 2013 Sep;146(5):1213-1219. |
| Purvis T, Pollack M, Coalson JJ, McNeish L, Williams III RO, Peters JI. Efficacy of Tacrolimus Nanoparticles Using In Vitro Cellular Assays for Immune Function.(submitted) Respiratory & Critical Care Medicine 2013 Aug;. |
| Burks ML, Brooks EG, Hill VL, Peters JI, Wood PR. Assessing proxy reports: agreement between children with asthma and their caregivers on quality of life Ann Allergy Asthma Immunol 2013 Jul;111(1):14-19. |
| Pamela R Wood, Vanessa L Hill, Margaret L Burks, BA; Jay I Peters, Harjinder Singh, Thirumalai R Kannan, Shruthi Vale, Marianna P Cagle, Molly F R Principe Joel B Baseman, Edward G Brooks,. Mycoplasma pneumoniae in children with acute and refractory asthma Ann Allergy Asthma Immunol 2013 May;110(5):328-334. |
| Maselli DJ, Adams SG, Peters JI, Levine SM. Management of asthma during pregnancy Therapeutic Advances in Respiratory Diseases 2013 Apr;7(2):87-100. |
| Jagirdar J, Chikkamuniyappa, S, Sirohi, D., McCarthy MJ, Peters JI. Cystic lung lesions in Sjogren syndrome: analysis of lymphocyte subsets in tissue with clinico-radiologic-pathologic correlation Ann Diagn Pathol 2013 Feb;17(1):113-116. |
| Jagirdar J, Chikkamuniyappa S, Sirohi D, McCarthy MJ, Peters JI. Cystic lung lesions in Sjogren syndrome: analysis of lymphocyte subsets in tissue with clinico-radiologic-pathologic correlation Ann Diagn Pathol. 2013; 17:113 2013 Feb;17(1):113-116. |
| Dugas HL, Peters JI, Robert O Williams III. Nebulization of Mycophenolate Mofetil Inhalation Suspension: Comparison with Oral and Pulmonary Administration of Cellcept? International Journal of Pharmaceutics 2013 Jan;441(1-2):19-29. |
| Peters JI, Singh, H., Brooks EG, Diaz, J., Kannan TR, Coalson JJ, Baseman, J, Cagle, M., Baseman JB. Persistence of Community-Acquired Respiratory Distress Syndrome Toxin-Producing Mycoplasma pneumoniae in Refractory Asthma Chest 2011 Aug;140(2):401-407. |
| Hardy, RD, Coalson JJ, Peters, JI, Chaparro, A, Techasaensiri, C, Cantwell AM, Kannan TR, Baseman JB, Dube PH. Analysis of Pulmonary Inflammation and Function in the Mouse and Baboon after Exposure to Mycoplasma pneumoniae CARDS Toxin Public Library of Science (PLoS ONE) 2009 Oct;4(10). |
Not Specified |
| Peters JI. A case of Mycobacterium simiae mimicking malignancy Inter J Pulm & Res sci 2018 Mar;2(5):001-002. |
| Peters JI, Maselli DJ. Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation o fexacerbations, emergency department visits, lung function, and oral corticosteroid use Dove Press Journal: therapeutics and Clinical Risk Management 2018 Feb;14. |
| Peters JI. Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection Industrial Pharmacy 2017 Feb;. |
| Peters JI. Iatrogenic Endobronchial bleeding: speed things up or cool it down? Interventional Pulmonology 2015 Jul;. |
| Peters JI. Adding tiotropium to ICSs alone or with LABAS improves pulmonary function in asthma Annals of Internal Medicine 2015 Jun;. |
| Peters JI. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powser via pulmonary administration in rats Biopharmaceutics 2014 Sep;. |
| Peters JI. In vitro and in vivo performance of dry powder inhalation formulations:comparison of particles prepared by thin film freezing and micronization AAPS PharmSciTech 2014 Aug;. |
| Peters JI. Effect of inhaled tacrolimus on ishemia reperfusion injury in rat lung transplant model Cardiovascular surgery 2013 Nov;. |
| Peters JI. Assessing proxy reports: agreement between children with asthma and their caregivers on quality of life Annals of Allergy, Asthma 2013 Oct;. |
| Peters JI. Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL : a retrospective study Annals of allergy, Asthma and Innumology 2013 Jun;. |
| Adams SG, Peters JI. ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD Ann Intern Med 2013 Mar;158(6):3-3. |
| Peters JI. Nebulization of mycophenolate mofetil inhalation suspensionin rats: comparison with oral and pulmonary administration of cellcept International Journal of Pharmaceutics 2013 Jan;. |
Review Article |
| Yi-Bo Wang, Alan B. Watts, Peters JI, Robert O. Williams III. The Impact of Pulmonary Diseases on the Fate of Inhaled Medicines International Journal of Pharmaceutics 2014 Jan;461(1-2):112-128. |
Federal |
|
| Funding Agency | NIH |
| Title | Genetic Epidemiology of Chronic Obstructive Pulmonary Disease |
| Status | Active |
| Period | 9/2007 - Present |
| Role | Co-Investigator |
| Grant Detail | Genetic Epidemiology of Chronic Obstructive Pulmonary Disease. The original local grant was approximately $1.2 million. Renewal - 7/1/2017-7/31/2018 |
Private |
|
| Funding Agency | Merrell-Dow |
| Title | Use of Deflazocort in Chronic Asthma |
| Status | Active |
| Period | 10/1990 - Present |
| Role | Principal Investigator |
| Grant Detail | |
| Funding Agency | Lung Therapeutics/UT School of Pharmacy |
| Title | Development of Inhaled Tacrolimus Nanoparticles in Acute Lung Injury |
| Status | Active |
| Period | 6/2017 - 6/2019 |
| Role | Co-Investigator |
| Grant Detail | This grant uses thin film freezing to create nanoparticles that are delivered in the form of brittle matrix that dispense to both large/small airways and the alveolar surface. Patents belong to UT Health San Antonio/UT School of Pharmacy. |
| Funding Agency | Wilford Foundation |
| Title | Creation of a Marmoset Model of Mycobacterium Avium Complex |
| Status | Active |
| Period | 6/2015 - 6/2019 |
| Role | Co-Investigator |
| Grant Detail | Develop a primate model of non tuberculous mycobacterial (NTM) pulmonary diseases |
| Funding Agency | UT Health at San Antonio Med/Pulmonary Diseases Divisional Funds |
| Title | Mycoplasma Pneumoniae Infection in Patients with Chronic Asthma - Data Analysis |
| Status | Active |
| Period | 11/2017 - 11/2018 |
| Role | Co-Investigator |
| Grant Detail | Data analysis of research data compiled from Dr. Joel Baseman`s NIH grant, Role of unique ADP-ribosylating vaculolating Mycoplasma penumoniae toxin in asthma, Grant Number: U19AI070412 |
| Funding Agency | Gates Foundation |
| Title | Role of Alveolar Macrophage Function in Tuberculosis |
| Status | Active |
| Period | 7/2017 - Present |
| Role | Principal Investigator |
| Grant Detail | Major goals: Obtain blood monocytes and alveolar macrophages from healthy volunteers for the Texas BioMedical Research Institute to study their role in prevention and resolution of infection from M. tuberculosis |